Sunshine Biopharma Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Sunshine Biopharma Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Sunshine Biopharma Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 1.27M shares.
  • Sunshine Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 24.3M shares, a 60.3% increase from 2022.
  • Sunshine Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 15.2M shares, a 481% increase from 2021.
  • Sunshine Biopharma Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 2.61M shares, a 156% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 1.27M +1.25M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 49.7K* +37.1K Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 641K +421K +191% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 24.3M +9.15M +60.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 12.8K* -18.9M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 12.7K* -15.8M Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-08-20
Q1 2023 220K -5.05M -95.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 15.2M +12.6M +481% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 18.9M +16.3M +643% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 15.8M +13.5M +562% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 5.27M +3.08M +140% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-06
Q4 2021 2.61M +1.59M +156% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-04
Q3 2021 2.54M -278M -99.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 2.39M -151M -98.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 2.19M -35.4M -94.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 1.02M -9.91M -90.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 281M +273M +3297% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 153M +148M +2978% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 37.6M +33.3M +773% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 10.9M +7.89M +259% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 8.27M -41.7M -83.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 4.97M -45M -90.1% Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 4.3M -42.8M -90.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 3.05M -40.6M -93% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-01
Q3 2018 50M -858M -94.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 50M -807M -94.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 47.1M -759M -94.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 43.6M -381M -89.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-12
Q3 2017 908M +645M +246% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 857M +595M +227% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-17
Q1 2017 806M +590M +274% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-22
Q4 2016 425M +303M +247% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 262M +132M +102% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-15
Q2 2016 262M +142M +119% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 216M +151M +233% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 122M +56.1M +84.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 130M +62.2M +91.8% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 120M +54.4M +83.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-16
Q1 2015 64.7M +3.56M +5.83% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 66.1M +10.7M +19.4% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-25
Q3 2014 67.8M +10.9M +19.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 65.5M +8.9M +15.7% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 61.1M +5.73M +10.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 55.4M +5.62M +11.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 56.9M +6.68M +13.3% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 56.6M +7.84M +16.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 55.4M +6.67M +13.7% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 49.8M +18.9M +61.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-19
Q3 2012 50.2M +19.5M +63.4% Jul 1, 2012 Sep 30, 2012 10-Q 2012-11-08
Q2 2012 48.7M +17.9M +58.2% Apr 1, 2012 Jun 30, 2012 10-Q 2012-08-08
Q1 2012 48.7M +18.1M +58.8% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 30.9M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 30.7M +1.05M +3.53% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 30.8M +1M +3.36% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 30.7M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-08
Q3 2010 29.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 29.8M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.